ethyl loflazepate

Subscribe to Selected New Research on ethyl loflazepate

7 relevant articles (1 outcomes, 1 trials/studies) found for this Bio-Agent

Description: structure given in first source

Also Known As:

CM 6912; Sanofi Synthelabo brand of ethyl loflazepate; Victan; ethyl flucozepate; 1H-1,4-benzodiazepine-3-carboxylic acid, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, ethyl ester

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 23

2-Ring Heterocyclic Compounds

Benzazepines: 2

Benzodiazepines: 4045

ethyl loflazepate: 7

Experts

1.	Soma, Kazui: 1 article (03/2005)
2.	Nishikawa, Takashi: 1 article (03/2005)
3.	Kamijo, Yoshito: 1 article (03/2005)
4.	Hayashi, Izumi: 1 article (03/2005)
5.	Yoshimura, Kuniko: 1 article (03/2005)

Related Diseases

1.	Neurotic Disorders (Neuroses) 01/01/1989 - "Comparison of therapeutic efficacy of neuroses between CM6912 (ethyl loflazepate) and diazepam in a double-blind trial." Get all the results and reference details, order at left...
2.	Ganglion Cysts (Ganglion) 07/01/1985 - "CM 6912 (5 mg/kg, i.v.) did not affect cardiovascular responses to the carotid occlusion, vagus stimulation, and pre- and post-ganglionic stimulation of cardiac ganglion in anesthetized dogs" Get all the results and reference details, order at left...
3.	Kidney Failure (Renal Failure) 01/01/1989 - "These results indicate the absence of a risk of accumulation of the 2 main and active metabolites of ethyl loflazepate in patients with renal failure." 01/01/1989 - "The kinetics of ethyl loflazepate were studied in patients with various degrees of renal failure" 01/01/1989 - "Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in man." Get all the results and reference details, order at left...
4.	Vomiting 12/01/1997 - "Antiemetic effect and safety of concurrent administration of ondansetron and other antiemetics (dexamethasone, domperidone and ethyl loflazepate), given for complete suppression of nausea/vomiting, were examined in 46 patients (109 courses) with gynecological cancer receiving single high-dose of cisplatin or carboplatin" Get all the results and reference details, order at left...
5.	Seizures (Seizure) 11/01/1983 - "Ethyl loflazepate was more potent than diazepam, nitrazepam and lorazepam in preventing pentetrazol-induced convulsion" Get all the results and reference details, order at left...
10 Diseases and 7 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Diazepam (Valium)
2.	ethyl loflazepate
3.	Ondansetron (Zofran)
4.	Fluvoxamine (Luvox)
5.	Carboplatin (JM8)
6.	Nitrazepam (Serenade)
7.	Lorazepam (Ativan)
8.	Domperidone (Domperidon)
9.	Dihydrotachysterol (AT 10)
10.	Dexamethasone (Maxidex)
13 Drugs and Important Bio-Agents and 6 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>